Introduction to Antidiabetic Agents & Local Anesthetics
The final unit covers two clinically vital drug classes. Antidiabetic agents manage Diabetes Mellitus — from Insulin preparations to five classes of oral hypoglycemics (Sulfonylureas, Biguanides, Thiazolidinediones, Meglitinides, and α-Glucosidase Inhibitors). Local Anesthetics reversibly block nerve conduction to produce pain-free surgical conditions. Understanding the SAR of local anesthetics — how the aromatic ring, intermediate chain, and terminal amine affect potency, duration, and toxicity — is a classic exam topic.
Syllabus & Topics
- 1Diabetes Mellitus – Overview: Type 1 (insulin-dependent, autoimmune destruction of β-cells) and Type 2 (non-insulin dependent, insulin resistance + relative insulin deficiency). Hyperglycemia → micro/macrovascular complications.
- 2Insulin: 51-amino acid protein hormone (A chain: 21 AA, B chain: 30 AA, linked by 2 disulfide bonds). Produced by β-cells of Islets of Langerhans. Preparations: Regular insulin (rapid onset, short duration), NPH/Isophane insulin (intermediate), Insulin Glargine (long-acting basal), Insulin Lispro/Aspart (ultra-rapid analogues).
- 3Sulfonylureas – First Generation: Tolbutamide (safest, shortest acting, used in elderly), Chlorpropamide (longest acting, causes hyponatremia due to SIADH-like effect). Mechanism: bind SUR1 on β-cell → close K⁺-ATP channels → depolarization → Ca²⁺ influx → insulin secretion.
- 4Sulfonylureas – Second Generation: Glipizide (rapid onset, pre-meal dosing), Glimepiride (once daily, least hypoglycemia risk among SUs). 100-200x more potent than first-generation. Require functional β-cells → ineffective in Type 1 DM.
- 5Biguanides: Metformin – first-line drug for Type 2 DM. Mechanism: activates AMP-activated protein kinase (AMPK) → ↓hepatic gluconeogenesis, ↑peripheral glucose uptake, ↑insulin sensitivity. Does NOT cause hypoglycemia. Rare but fatal side effect: lactic acidosis (contraindicated in renal failure).
- 6Thiazolidinediones (Glitazones): Pioglitazone and Rosiglitazone – activate PPARγ (Peroxisome Proliferator-Activated Receptor gamma) nuclear receptors in adipose tissue → ↑insulin sensitivity by increasing glucose transporter (GLUT4) expression. Onset of action: 2-4 weeks. Risk: weight gain, edema, hepatotoxicity.
- 7Meglitinides (Glinides): Repaglinide and Nateglinide – short-acting insulin secretagogues. Same mechanism as sulfonylureas (close K⁺-ATP channels) but bind at a different site. Taken immediately before meals → control postprandial hyperglycemia. Rapid onset, short duration.
- 8α-Glucosidase Inhibitors: Acarbose and Voglibose – competitively inhibit α-glucosidase enzymes (maltase, sucrase) in the brush border of the small intestine → delay carbohydrate digestion and glucose absorption → ↓postprandial blood glucose spikes. Side effects: flatulence, abdominal bloating, diarrhea.
- 9Local Anesthetics – General SAR: A local anesthetic molecule consists of three structural domains: (1) Lipophilic aromatic ring (determines potency and duration). (2) Intermediate chain – ester (-COO-) or amide (-NHCO-) linkage (determines metabolic stability). (3) Hydrophilic terminal amine (determines onset and pKa).
- 10SAR of Local Anesthetics – Key Rules: ↑Lipophilicity of aromatic ring → ↑potency + ↑duration but ↑toxicity. Amide linkage is more metabolically stable than ester linkage (amides not hydrolyzed by plasma cholinesterases). Tertiary amines (better lipid solubility) are more potent than secondary amines.
- 11Benzoic Acid Derivatives: Cocaine (natural prototype – blocks Na⁺ channels AND inhibits catecholamine reuptake → vasoconstriction + addiction. Only LA causing vasoconstriction), Hexylcaine, Meprylcaine, Cyclomethycaine, Piperocaine.
- 12Amino Benzoic Acid Derivatives (Esters): Benzocaine (only topical – secondary amine, not ionizable at physiological pH), Butamben, Procaine* (Novocain – prototype injectable ester LA, synthesis required), Butacaine, Propoxycaine, Tetracaine (10x more potent than procaine, spinal anesthesia), Benoxinate (ophthalmic).
- 13Anilide/Lidocaine Derivatives (Amides): Lignocaine/Lidocaine (prototype amide LA – faster onset, longer duration than procaine, not hydrolyzed by cholinesterases), Mepivacaine (less vasodilation → can be used without vasoconstrictor), Prilocaine (causes methemoglobinemia), Etidocaine (very long-acting).
Learning Objectives
Frequently Asked Questions (FAQs)
Q1. Why Doesn’t Metformin Cause Hypoglycemia?
Metformin activates AMPK, which decreases hepatic glucose production and increases peripheral insulin sensitivity. Importantly, it does not stimulate insulin secretion from pancreatic β-cells (unlike sulfonylureas). Because it does not increase circulating insulin levels, blood glucose does not fall below normal physiological limits, making hypoglycemia extremely rare with metformin monotherapy.
Q2. What Is the Difference Between Ester and Amide Local Anesthetics?
Ester local anesthetics such as Procaine and Tetracaine contain a –COO– linkage and are rapidly hydrolyzed by plasma cholinesterases, resulting in shorter duration of action. Their metabolite, para-aminobenzoic acid (PABA), may cause allergic reactions.
Amide local anesthetics such as Lidocaine and Mepivacaine contain a –NHCO– linkage and are metabolized more slowly by hepatic CYP450 enzymes, giving longer duration. Allergic reactions to amide anesthetics are rare.
Q3. Why Is Cocaine Unique Among Local Anesthetics?
Cocaine uniquely blocks voltage-gated sodium channels and also inhibits reuptake of norepinephrine and dopamine at sympathetic nerve terminals. This produces both local anesthesia and vasoconstriction (useful in nasal surgery), as well as central nervous system stimulation and euphoria, contributing to its high abuse potential. Most other local anesthetics cause vasodilation.
Q4. How Do Sulfonylureas Stimulate Insulin Release?
Sulfonylureas such as Glipizide and Glimepiride bind to the SUR1 subunit of ATP-sensitive potassium (K⁺-ATP) channels on pancreatic β-cells. This closes the channel, leading to membrane depolarization, opening of voltage-gated Ca²⁺ channels, calcium influx, and exocytosis of insulin granules. This mechanism requires functional β-cells and is therefore ineffective in Type 1 diabetes.
Q5. Why Does Benzocaine Only Work Topically?
Benzocaine is a primary amine with a low pKa (~3.5). At physiological pH, it exists predominantly in the non-ionized form, allowing good membrane penetration for topical anesthesia. However, it cannot form sufficient intracellular ionized species required to effectively block sodium channels from the inside, and it cannot be formulated as a water-soluble injectable salt, limiting its use to topical applications.